Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
First and only AFib ablation products to receive approval for use in a workflow without fluoroscopy from the U.S. Food and Drug Administration
Enables workflows with zero fluoroscopy during catheter ablation procedures
Approval based on data from REA... Devices, Cardiology, FDA Biosense Webster, THERMOCOOL SMARTTOUCH, PENTARAY, Atrial Fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 4, 2023 Category: Pharmaceuticals Source Type: news
Kyverna Therapeutics Extends Series B Financing Round to $145 Million and Brings in New Investors
Bain Capital Life Sciences and GordonMD® Global Investments LP join existing investors
Proceeds to support clinical development of novel fully human anti-CD19 CAR T-cell therapies for autoimmune diseases
EMERYVILLE, Calif., Aug. 3, 2023 -- (Healt... Biopharmaceuticals, Venture Capital Kyverna Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 3, 2023 Category: Pharmaceuticals Source Type: news
Body Vision Medical Forges Exclusive Distribution Agreements to Extend Global Access to LungVision(TM) AI Imaging System
Body Vision Medical announces three strategic distribution agreements for Hong Kong, Macao and the entire Greater Bay Area (GBA), Australia and New Zealand, and Romania
CAMPBELL, Calif., Aug. 2, 2023 -- (Healthcare Sales & Marketing Network) -- Body Vi... Devices, Radiology, Surgery, Distribution Body Vision Medical, LungVision, intraoperative imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 2, 2023 Category: Pharmaceuticals Source Type: news
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
Single Test on BD MAX System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample
FRANKLIN LAKES, N.J., Aug. 1, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leadi... Diagnostics, FDA BD , Respiratory Viral Panel, SARS-CoV-2, Respiratory Syncytial Virus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 1, 2023 Category: Pharmaceuticals Source Type: news
Viatris Announces Launch of Breyna(TM) (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, the First FDA-Approved Generic Version of Symbicort(R) for People with Asthma and Chronic Obstructive Pulmonary Disease, in Partnership with Kindeva
Launch demonstrates companies' commitment to bringing complex generic medicines to the market to help increase patient access
PITTSBURGH and WOODBURY, Minn., July 31, 2023 -- (Healthcare Sales & Marketing Network) -- Viatris Inc. (NASDAQ: VTRS), a glob... Biopharmaceuticals, Generics, Product Launch Viatris , Kindeva Drug Delivery, Breyna , Symbicort (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 31, 2023 Category: Pharmaceuticals Source Type: news
FDA Grants Clearance for UltraSight's AI-Powered Cardiac Ultrasound Technology
New AI guidance software will allow more medical professionals to conduct cardiac ultrasound in multiple care settings expanding patient access to cardiac imaging
TEL AVIV, Israel, July 27, 2023 -- (Healthcare Sales & Marketing Network) -- Today, Ultra... Devices, Cardiology, Radiology, FDA UltraSight, cardiac imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 27, 2023 Category: Pharmaceuticals Source Type: news
iotaMotion Completes $12M Series A Raise to Accelerate Commercial Expansion of iotaSOFT(R) Insertion System
IOWA CITY, Iowa, July 26, 2023 -- (Healthcare Sales & Marketing Network) -- iotaMotion, Inc., a leader in developing advanced robotic-assisted systems for cochlear implant surgery, announced today the company has oversubscribed its $12 million Series A ca... Devices, Surgery, Venture Capital iotaMotion, iotaSOFT, cochlear implant (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 26, 2023 Category: Pharmaceuticals Source Type: news
Beckman Coulter Receives FDA Clearance for DxC 500 AU Chemistry Analyzer, Expanding Portfolio with Proven Six Sigma Performance
ANAHEIM, Calif., July 25, 2023 -- (Healthcare Sales & Marketing Network) -- Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the compan... Diagnostics, FDA Beckman Coulter, DxC 500 AU, Chemistry Analyzer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 25, 2023 Category: Pharmaceuticals Source Type: news
Heron Therapeutics Announces Cost Reduction Plan and Restructuring
Expected overall cash savings of $75 million through 2025
New executive management team in place
SAN DIEGO, July 24, 2023 -- (Healthcare Sales & Marketing Network) -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company ... Biopharmaceuticals Heron Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 24, 2023 Category: Pharmaceuticals Source Type: news
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
FRANKLIN LAKES, N.J., July 24, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX) Chairman, CEO and President Tom Polen issued the following message regarding the U.S. Food and Drug Administration (FDA) 510(k)... Devices, FDA BD , Alaris Infusion System (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 24, 2023 Category: Pharmaceuticals Source Type: news
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
LISLE, Ill., July 21, 2023 -- (Healthcare Sales & Marketing Network) -- Hubly Surgical, a leader in neurosurgical innovation, has successfully closed its Series Seed funding round at an oversubscribed $3 million. The investment comes on the heels of the c... Devices, Neurosurgery, Venture Capital Hubly Surgical, Hubly Drill (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 21, 2023 Category: Pharmaceuticals Source Type: news
Boehringer Ingelheim Receives FDA Approval for NexGard(R) PLUS (afoxolaner, moxidectin and pyrantel chewable tablets): A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites
The maker of HEARTGARD® Plus (ivermectin/pyrantel), the #1 vet-recommended and #1 dog-preferred real beef chew,1, 2 introduces the latest innovation in its portfolio combination parasite protection for dogs in a single, monthly, beef-flavored soft ch... Biopharmaceuticals, Veterinary, FDA Boehringer Ingelheim, NexGard PLUS, afoxolaner, moxidectin, pyrantel (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2023 Category: Pharmaceuticals Source Type: news
MediView Receives FDA 510(k) Clearance for XR90 Augmented Reality-Based Visualization and Navigation Platform
CLEVELAND, July 20, 2023 -- (Healthcare Sales & Marketing Network) -- MediView XR, Inc., a leading clinical augmented reality med-tech company, announced today it received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for i... Devices, Surgery, FDA MediView XR, XR90, augmented reality (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 20, 2023 Category: Pharmaceuticals Source Type: news
Velia Therapeutics Announces Appointment of Veteran Drug Developer, John McHutchison, AO, MD as President and Chief Executive Officer
Dr. McHutchison is a world-renowned physician, scientist, and drug developer who has led the research and development of numerous marketed therapies for chronic hepatitis B (HBV), chronic hepatitis C (HCV) and multiple other serious diseases.
Dr. McHutc... Biopharmaceuticals, Personnel Velia Therapeutics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2023 Category: Pharmaceuticals Source Type: news
GT Medical Technologies Highlights Glioblastoma (GBM) Awareness Day July 19 and Ongoing GammaTile(R) Therapy Clinical Studies
TEMPE, Ariz., July 19, 2023 -- (Healthcare Sales & Marketing Network) -- In 2018, inspired by John McCain's courageous battle with glioblastoma (GBM), a bipartisan group of senators passed a resolution to focus the nation's attention on GBM, which is the ... Devices, Oncology GT Medical Technologies, GammaTile, brain tumor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2023 Category: Pharmaceuticals Source Type: news
